IP Library › Granted Patent US 7,655,761
Granted Patent B2
US 7,655,761 · App. 11/952,802 · Granted Feb 2, 2010

IL-17-like cytokine binding compounds and antibodies

Assignee: Schering Corporation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,655,761
App. No.
11/952,802
Granted
Feb 2, 2010
Kind
B2
Abstract

CTLA-8 related antigens from mammals, reagents related thereto including purified proteins, specific antibodies, and nucleic acids encoding said antigens. Methods of using said reagents and diagnostic kits are also provided.

Claims (3)

1. A binding compound comprising an antigen binding portion from an antibody which binds with selectivity to a polypeptide comprising the amino acid residues 1-145 of SEQ ID NO:14.

2. The binding compound of claim 1 , wherein the antibody is a monoclonal antibody.

3. A monoclonal antibody which binds with selectivity to a polypeptide comprising the amino acid residues 1-145 of SEQ ID NO:14.

Assignments (1)
CHANGE OF NAME Recorded Aug 30, 2012
From: SCHERING CORPORATION
To: MERCK SHARP & DOHME CORP.
Reel/Frame 028884/0151 →
Continuity (6)
Continuation 1160455900 · Nov 27, 2006
Continuation 1074222000 · Dec 19, 2003
Division 1036679100 · Feb 14, 2003
Division 0948029700 · Jan 10, 2000
Provisional Application 6011550600 · Jan 11, 1999
Related Publication 20080085262A1 · Apr 10, 2008